63 related articles for article (PubMed ID: 38485877)
1. The heart and pulmonary arterial hypertension in systemic sclerosis.
Vandecasteele EH; De Pauw M; Brusselle G; Decuman S; Piette Y; De Keyser F; Smith V
Acta Clin Belg; 2016 Feb; 71(1):1-18. PubMed ID: 27075793
[TBL] [Abstract][Full Text] [Related]
2. Skin disease: a cardinal feature of systemic sclerosis.
Krieg T; Takehara K
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii14-8. PubMed ID: 19487217
[TBL] [Abstract][Full Text] [Related]
3. Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis.
Zhao Y; Xu W; Gao W; Li X; Liu B; Yan S; Ma Z; Yang Q
Clin Rheumatol; 2024 May; 43(5):1635-1646. PubMed ID: 38485877
[TBL] [Abstract][Full Text] [Related]
4. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E;
Arthritis Rheumatol; 2019 Sep; 71(9):1553-1570. PubMed ID: 30969034
[TBL] [Abstract][Full Text] [Related]
5. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
6. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
7. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
[TBL] [Abstract][Full Text] [Related]
8. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Mueller-Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N;
Ann Rheum Dis; 2015 Apr; 74(4):730-7. PubMed ID: 24389298
[TBL] [Abstract][Full Text] [Related]
9. Rapid and Sustained Effect of Ozone Major Autohemotherapy for Raynaud and Hand Edema in Systemic Sclerosis Patient: A Case Report.
Galluccio F
Cureus; 2022 Nov; 14(11):e31831. PubMed ID: 36440300
[TBL] [Abstract][Full Text] [Related]
10. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.
Cole A; Ong VH; Denton CP
Clin Rev Allergy Immunol; 2023 Jun; 64(3):378-391. PubMed ID: 35648373
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes.
Tieu A; Chaigne B; Dunogué B; Dion J; Régent A; Casadevall M; Cohen P; Legendre P; Terrier B; Costedoat-Chalumeau N; Le Jeunne C; Mouthon L
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626223
[TBL] [Abstract][Full Text] [Related]
12. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Zanatta E; Huscher D; Ortolan A; Avouac J; Airò P; Balbir-Gurman A; Siegert E; Matucci Cerinic M; Cozzi F; Riemekasten G; Hoffmann-Vold AM; Distler O; Gabrielli A; Heitmann S; Hunzelmann N; Montecucco C; Morovic-Vergles J; Ribi C; Doria A; Allanore Y;
Rheumatology (Oxford); 2022 Nov; 61(12):4786-4796. PubMed ID: 35348643
[TBL] [Abstract][Full Text] [Related]
13. Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.
Rhodes CJ; Wharton J; Swietlik EM; Harbaum L; Girerd B; Coghlan JG; Lordan J; Church C; Pepke-Zaba J; Toshner M; Wort SJ; Kiely DG; Condliffe R; Lawrie A; Gräf S; Montani D; Boucly A; Sitbon O; Humbert M; Howard LS; Morrell NW; Wilkins MR
Am J Respir Crit Care Med; 2022 May; 205(9):1102-1111. PubMed ID: 35081018
[No Abstract] [Full Text] [Related]
14. Prognostic nutritional index (PNI), independent of frailty is associated with six-month postoperative mortality.
Cadwell JB; Afonso AM; Shahrokni A
J Geriatr Oncol; 2020 Jun; 11(5):880-884. PubMed ID: 32253157
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
